Compare · BYAH vs ECL
BYAH vs ECL
Side-by-side comparison of Park Ha Biological Technology Co. Ltd. (BYAH) and Ecolab Inc. (ECL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BYAH and ECL operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- ECL is the larger of the two at $77.67B, about 9858.3x BYAH ($7.9M).
- Over the past year, BYAH is down 98.7% and ECL is up 0.7% - ECL leads by 99.4 points.
- ECL has hit the wire 15 times in the past 4 weeks while BYAH has been quiet.
- ECL has more recent analyst coverage (25 ratings vs 0 for BYAH).
- Company
- Park Ha Biological Technology Co. Ltd.
- Ecolab Inc.
- Price
- $1.92-21.95%
- $280.79+1.36%
- Market cap
- $7.9M
- $77.67B
- 1M return
- -5.57%
- +0.47%
- 1Y return
- -98.72%
- +0.67%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 0
- 15
- Recent ratings
- 0
- 25
Ecolab Inc.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services worldwide. Its Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, and petrochemical industries. The company's Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in St. Paul, Minnesota.
Latest BYAH
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- New insider Wang Li (Alya) claimed ownership of 187,500 units of Class A Ordinary Shares (SEC Form 3)
- CFO Zhu Xiaoyan was granted 112,500 units of Class A Ordinary Shares (SEC Form 4)
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form S-8 filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
Latest ECL
- Director Zillmer John J was granted 131 shares, increasing direct ownership by 0.27% to 49,540 units (SEC Form 4)
- Director Whalen Julie was granted 131 shares, increasing direct ownership by 28% to 604 units (SEC Form 4)
- Director Vautrinot Suzanne M was granted 131 shares, increasing direct ownership by 1% to 11,960 units (SEC Form 4)
- Director Nowell Lionel L Iii was granted 131 shares, increasing direct ownership by 2% to 6,922 units (SEC Form 4)
- Director Mckibben Tracy B was granted 131 shares, increasing direct ownership by 1% to 11,821 units (SEC Form 4)
- Director Maclennan David was granted 178 shares, increasing direct ownership by 0.70% to 25,625 units (SEC Form 4)
- Director Larson Michael was granted 131 shares, increasing direct ownership by 0.68% to 19,326 units (SEC Form 4)
- Director Gross Marion K. was granted 131 shares, increasing direct ownership by 22% to 730 units (SEC Form 4)
- Director Green Eric Mark was granted 276 shares, increasing direct ownership by 3% to 8,234 units (SEC Form 4)
- Director Doukeris Michel D was granted 131 shares, increasing direct ownership by 2% to 8,590 units (SEC Form 4)